Glaxo in for competition after Hikma’s generic asthma drug passes major milestone – Telegraph.co.uk


Telegraph.co.uk

Glaxo in for competition after Hikma's generic asthma drug passes major milestone
Telegraph.co.uk
Cheap versions of one of GlaxoSmithKline's top-selling asthma drugs could be available to patients as early as next year. Jordanian pharmaceuticals company Hikma moved one step closer to getting a generic version of Glaxo's Advair Diskus inhaler onto
Cipla's rival Hikma gets asthma drug nod in the USMoneycontrol.com
Vectura and Hikma's generic of Advair Diskus accepted for filing by US FDAThe Pharma Letter (registration)
Vectura Group PLC and Hikma shares given FDA boostProactive Investors UK

all 8 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.